- Sort by Popularity (sales)
- Display 15 Products per page
Cell and Gene Therapy Deals Analysis, 2021-2024
Published: June 3, 2024 | Price: $6,300.00 – $12,600.00
Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 is published in two installments, the first in Q2 2024 and the second in Q4 2024. Customers who purchase the report will receive both installments. Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that...
Histology and Cytology IVD Market Update, 2024
Published: May 21, 2024 | Price: $5,000.00 – $10,500.00
Histology and Cytology IVD Market Update, 2024 provides an in-depth competitive analysis of the histology/cytology market from 2023 to 2028. The forecasted market analysis from 2023 to 2028 is based on demographic trends, new technological developments, innovative products, and global market expansion. This comprehensive review offers insights into the future direction of the histology and cytology IVD market, highlighting the potential for growth and advancements. Histology and cytology have long been essential components of pathological laboratories, offering critical insights into...
Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
Published: April 30, 2024 | Price: $5,000.00 – $10,500.00
Authoritative market research on cell therapy, gene therapy, and RNA therapy analyzing markets by disease type Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body's immune system. Recent years have seen an increase in new therapies and the pipeline indicates this trend will continue. A large range of therapeutic areas from oncology to cardiology have seen rapidly proliferating clinical trials. Cell...
Molecular Diagnostics Quarterly Datastream, 2024
Published: November 30, 2024 | Price: $10,500.00
NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports. The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition
Published: April 23, 2024 | Price: $7,000.00 – $14,000.00
NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028. Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient's home. Over the past two decades, Kalorama Information has observed that POC tests present significant...
In Vitro Diagnostic (IVD) Trends and Market Update: December 2024
Published: December 6, 2024 | Price: $5,000.00 – $10,500.00
The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product developments, shifts in global health spending, regulatory changes, and disease trends, maintaining its resilience. Several segments within the IVD market are experiencing significant growth and...
The IVD Market in South Korea, 2024
Published: February 26, 2024 | Price: $5,000.00 – $10,500.00
The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea's IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences. The report...
The World Market for Vaccines, 2024
Published: February 22, 2024 | Price: $5,000.00 – $10,500.00
Vaccines offer long-term or permanent immunity against diseases. They have been a cornerstone of preventive medicine for over 70 years, stimulating an immune response to specific diseases. The widespread adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related deaths are now rare in developed nations and decreasing globally. Smallpox has been eradicated, polio eliminated...
The World Market for Veterinary Diagnostics, 7th Edition
Published: January 22, 2024 | Price: $5,000.00 – $10,500.00
Diagnostic testing plays a crucial role in animal healthcare, offering veterinarians a diverse range of tests for disease identification and monitoring. The efficacy of diagnostic testing relies on swift, reliable, and accurate methods, facilitating informed diagnoses. Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory. This sector presents a rapidly expanding market opportunity for in vitro diagnostic (IVD) companies and others who can leverage the ongoing demand to ensure agricultural...
The Worldwide Market for Liquid Biopsy, 6th Edition
Published: December 29, 2023 | Price: $5,000.00 – $10,000.00
Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...
The World Market for Molecular Diagnostics, 12th Edition
Published: December 19, 2023 | Price: $3,750.00 – $7,500.00
Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...
Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023
Published: December 8, 2023 | Price: $5,000.00 – $10,000.00
While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years. Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area. There are now many approved therapies with proven track records. As the technologies have lowered the barriers to entry for the industry, over 1,500 therapy or tools companies have been...
Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
Published: November 29, 2023 | Price: $5,000.00 – $10,000.00
In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare. For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost. While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...
Remote Patient Monitoring and Telehealth Markets, 13th Edition
Published: November 27, 2023 | Price: $5,000.00 – $10,000.00
Telehealth and remote patient monitoring have become integral to improving health conditions and preventing health complications. The transformations observed during the pandemic have bolstered telemedicine and, consequently, remote patient monitoring, instilling confidence in virtual patient assessment and access to advanced technological monitoring. Since January 2019, remote patient monitoring has experienced a significant surge, and current telehealth systems are leveraging key technologies increasingly prevalent in the health industry to foster further growth. Kalorama Information analyzes these trends and more in Remote...
In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
Published: November 7, 2023 | Price: $3,750.00 – $7,500.00
In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors...